David Lum

8PUBLICATIONS

124CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 26, 2026

BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

|Apr 22, 2026

Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

|Jul 01, 2024

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Eric A Smith, Rachel L Belote, Nelly M Cruz

|Jun 18, 2024

Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral Fibrosis.

Surbhi Verma, Stephanie D Giagnocavo, Meghan C Curtin

|Dec 15, 2023

Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

|Nov 06, 2023

Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression.

Gennie L Parkman, Tursun Turapov, David A Kircher

Pageof 2

Frequent Collaborators

Kevin B Jones

Jeffrey H Chuang

Bryan E Welm

Alana L Welm

Robert L Judson-Torres

2 joint publications

Katarzyna Modzelewska

Sandra D Scherer

Steffi Oesterreich

Feng Chen

Craig M Rush

Frequent Collaborators

Kevin B Jones

Jeffrey H Chuang

Bryan E Welm

Alana L Welm